0001415889-23-012375.txt : 20230818
0001415889-23-012375.hdr.sgml : 20230818
20230818070506
ACCESSION NUMBER: 0001415889-23-012375
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230817
FILED AS OF DATE: 20230818
DATE AS OF CHANGE: 20230818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Duncan Gregory Scott
CENTRAL INDEX KEY: 0001831127
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39811
FILM NUMBER: 231183758
MAIL ADDRESS:
STREET 1: 44 MILTON AVENUE
CITY: ALPHARETTA
STATE: GA
ZIP: 30009
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Virios Therapeutics, Inc.
CENTRAL INDEX KEY: 0001818844
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 854314201
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 44 MILTON AVENUE
CITY: ALPHARETTA
STATE: GA
ZIP: 30009
BUSINESS PHONE: 8666208655
MAIL ADDRESS:
STREET 1: 44 MILTON AVENUE
CITY: ALPHARETTA
STATE: GA
ZIP: 30009
FORMER COMPANY:
FORMER CONFORMED NAME: Virios Therapeutics, LLC
DATE OF NAME CHANGE: 20200721
4
1
form4-08182023_070801.xml
X0508
4
2023-08-17
0001818844
Virios Therapeutics, Inc.
VIRI
0001831127
Duncan Gregory Scott
C/O VIRIOS THERAPEUTICS, INC.
44 MILTON AVENUE
ALPHARETTA
GA
30009
true
true
false
false
CHIEF EXECUTIVE OFFICER
0
Common Stock
2023-08-17
4
P
0
25000
1.2498
A
57461
D
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.00 to $1.25, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the ranges set forth in this footnote to this Form 4.
/s/ Greg Duncan
2023-08-18